TrialThe Lancet. Child & adolescent health2020

Acceptability, safety, and patterns of use of oral tenofovir disoproxil fumarate and emtricitabine for HIV pre-exposure prophylaxis in South African adolescents: an open-label single-arm phase 2 trial.

Katherine Gill et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.